Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) kicked off on Friday, down -36.07% from the previous trading day, before settling in for the closing price of $18.91. Over the past 52 weeks, QNRX has traded in a range of $5.01-$41.80.
A company in the Healthcare sector has dropped its sales by -144.01% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 69.85%.
Quoin Pharmaceuticals Ltd ADR (QNRX) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The most recent insider transaction that took place on Oct 14 ’25, was worth 128,640. In this transaction Director of this company bought 15,152 shares at a rate of $8.49, taking the stock ownership to the 15,153 shares. Before that another transaction happened on Dec 23 ’24, when Company’s Chief Operating Officer bought 555,556 for $0.45, making the entire transaction worth $250,000. This insider now owns 602,648 shares in total.
Quoin Pharmaceuticals Ltd ADR (QNRX) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -9.73 earnings per share (EPS), higher than consensus estimate (set at -15.05) by 5.32. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.96 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 69.85% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 80.19% during the next five years compared to -144.01% drop over the previous five years of trading.
Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) Trading Performance Indicators
Take a look at Quoin Pharmaceuticals Ltd ADR’s (QNRX) current performance indicators. Last quarter, stock had a quick ratio of 1.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -469.79, a number that is poised to hit -4.02 in the next quarter and is forecasted to reach -6.91 in one year’s time.
Technical Analysis of Quoin Pharmaceuticals Ltd ADR (QNRX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.15 million. That was inferior than the volume of 0.29 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 19.66%.
During the past 100 days, Quoin Pharmaceuticals Ltd ADR’s (QNRX) raw stochastic average was set at 15.54%, which indicates a significant increase from 12.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.74 in the past 14 days, which was higher than the 1.50 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.40, while its 200-day Moving Average is $9.53. However, in the short run, Quoin Pharmaceuticals Ltd ADR’s stock first resistance to watch stands at $14.63. Second resistance stands at $17.16. The third major resistance level sits at $19.23. If the price goes on to break the first support level at $10.03, it is likely to go to the next support level at $7.96. The third support level lies at $5.43 if the price breaches the second support level.
Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) Key Stats
The company with the Market Capitalisation of 7.13 million has total of 839K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -8,960 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -3,950 K.
